Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Adamas Pharma (ADMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	12-2019	12-2018	12-2017	12-2016
Assets
Current Assets
Cash & Cash Equivalents	71,660	65,774	56,605	91,316	23,735
Marketable Securities	11,705	66,833	154,265	82,126	89,917
Receivables	8,042	5,770	5,511	367	794
Inventories	7,294	5,267	5,121	1,704	N/A
TOTAL	$111,736	$150,320	$228,373	$179,175	$116,987

Non-Current Assets
PPE Net	1,598	2,449	3,652	3,132	3,156
Investments And Advances	0	0	0	2,991	22,292
Other Non-Current Assets	6,695	9,389	2,789	878	38
TOTAL	$8,293	$11,838	$6,441	$7,001	$25,486

Total Assets	$120,029	$162,158	$234,814	$186,176	$142,473

Liabilities
Current Liabilities
Short Term Debt	3,657	2,041	1,664	N/A	N/A
Accounts payable and accrued liabilities	2,144	6,932	6,570	3,878	3,589
Accrued Expenses	27,164	16,117	15,530	12,385	5,867
Other current liabilities	1,902	1,858	512	344	287
TOTAL	$34,867	$26,948	$24,276	$16,607	$9,743

Non-Current Liabilities
Long Term Debt	126,307	125,674	117,457	102,647	N/A
Other Non-Current Liabilities	8,831	10,429	3,196	796	547
TOTAL	$135,138	$136,103	$120,653	$103,443	$547

Total Liabilities	$170,005	$163,051	$144,929	$120,050	$10,290

Shareholders' Equity
Shares Outstanding, K	30,568	28,013	27,449	26,807	22,220
Common Shares	34	33	32	28	27
Retained earnings	-505,287	-447,884	-342,698	-211,699	-122,209
Other shareholders' equity	0	16	-264	-167	-193
TOTAL	$-49,976	$-893	$89,885	$66,126	$132,183

Total Liabilities And Equity	$120,029	$162,158	$234,814	$186,176	$142,473